Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alzheimer's‐like signaling in brains of COVID‐19 patients

3 Feb 2022

Abstract excerpt

Abstract Introduction The mechanisms that lead to cognitive impairment associated with COVID‐19 are not well understood. Methods Brain lysates from control and COVID‐19 patients were analyzed for oxidative stress and inflammatory signaling pathway markers, and measurements of Alzheimer’s disease (AD)‐linked signaling biochemistry. Post‐translational modifications of the ryanodine receptor/calcium (Ca2 + ) release...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Intensive Care Unit Cognitive Disorders
Share to Long-Term Effects of COVID-19
Share to Pharmacological Receptor Mechanisms and Effects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35112786
DOI: 10.1002/alz.12558

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alzheimer's‐like signaling in brains of COVID‐19 patientsPMID 35112786Read ↗

Intersection of COVID-19 and Alzheimer's Disease: Genetic Insights and Neuropathological Consequences.Semantic proximity Read ↗

Single-nucleus RNA sequencing reveals the shared mechanisms inducing cognitive impairment between COVID-19 and Alzheimer’s diseaseSemantic proximity Read ↗

Deterioration of neuroimmune homeostasis in Alzheimer’s Disease patients who survive a COVID-19 infectionSemantic proximity Read ↗

Investigating the Potential Shared Molecular Mechanisms between COVID-19 and Alzheimer’s Disease via Transcriptomic AnalysisSemantic proximity Read ↗

Brain-wide alterations revealed by spatial transcriptomic and proteomic analyses in COVID-19 infectionSemantic proximity Read ↗

Alzheimer's disease and COVID-19: Interactions, intrinsic linkages, and the role of immunoinflammatory responses in this process.Semantic proximity Read ↗

Amyloid β production is regulated by β2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor.Semantic proximity Read ↗

Neurotoxic Amyloidogenic Peptides Identified in the Proteome of SARS-COV2: Potential Implications for Neurological Symptoms in COVID-19Semantic proximity Read ↗

Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairmentSemantic proximity Read ↗

Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairmentSemantic proximity Read ↗

Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19Semantic proximity Read ↗

Severe COVID-19 is associated with molecular signatures of aging in the human brainSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.